Moore Capital Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-30,000
| Closed | -$6.51M | – | 1063 |
|
|
2021
Q1 | $6.51M | Buy |
+30,000
| New | +$5.64M | 0.08% | 209 |
|
|
2019
Q4 | – | Sell |
-10,000
| Closed | -$1.15M | – | 377 |
|
|
2019
Q3 | $1.15M | Hold |
10,000
| – | – | 0.05% | 232 |
|
|
2019
Q2 | $1.72M | Hold |
10,000
| – | – | 0.04% | 237 |
|
|
2019
Q1 | $1.69M | Sell |
10,000
-5,000
| -33% | -$744K | 0.05% | 208 |
|
|
2018
Q4 | $1.46M | Sell |
15,000
-5,000
| -25% | -$656K | 0.06% | 162 |
|
|
2018
Q3 | $3.46M | Hold |
20,000
| – | – | 0.07% | 163 |
|
|
2018
Q2 | $2.79M | Buy |
20,000
+10,000
| +100% | +$1.42M | 0.07% | 170 |
|
|
2018
Q1 | $1.13M | Sell |
10,000
-10,000
| -50% | -$1.26M | 0.02% | 188 |
|
|
2017
Q4 | $2.64M | Buy |
20,000
+10,000
| +100% | +$1.17M | 0.05% | 177 |
|
|
2017
Q3 | $1.01M | Hold |
10,000
| – | – | 0.02% | 190 |
|
|
2017
Q2 | $1M | Hold |
10,000
| – | – | 0.03% | 155 |
|
|
2017
Q1 | $1.21M | Hold |
10,000
| – | – | 0.03% | 159 |
|
|
2016
Q4 | $1.12M | Buy |
+10,000
| New | +$1.2M | 0.04% | 144 |
|
|
2016
Q1 | – | Sell |
-40,500
| Closed | -$2.81M | – | 361 |
|
|
2015
Q4 | $2.81M | Buy |
+40,500
| New | +$3.3M | 0.09% | 181 |
|
|
2015
Q2 | – | Sell |
-25,000
| Closed | -$2.28M | – | 540 |
|
|
2015
Q1 | $2.28M | Buy |
+25,000
| New | +$2.03M | 0.05% | 259 |
|
|
2014
Q4 | – | Sell |
-13,500
| Closed | -$1.09M | – | 438 |
|
|
2014
Q3 | $1.09M | Sell |
13,500
-31,500
| -70% | -$2.79M | 0.03% | 337 |
|
|
2014
Q2 | $4.83M | Buy |
45,000
+10,800
| +32% | +$751K | 0.12% | 194 |
|
|
2014
Q1 | $2.03M | Buy |
+34,200
| New | +$2.03M | 0.04% | 270 |
|
Other funds holding GWPH
Moore Capital Management's GWPH Position: Q2 2021 in Review
Moore Capital Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 30,000 shares — an estimated $6.51M sold.
Moore Capital Management first reported a position in GWPH in Q1 2014 and held it in 18 quarters. The position peaked at $6.51M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Moore Capital Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Moore Capital Management sold 30,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $6.51M.
- Moore Capital Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 18 quarters.
- Moore Capital Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $6.51M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Moore Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.